Molecular Neurobiology of Drug Abuse

药物滥用的分子神经生物学

基本信息

  • 批准号:
    6436857
  • 负责人:
  • 金额:
    $ 12.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-09-30 至 2007-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (provided by the applicant) This is a Senior Scientist Award application for Dr. Donald M. Kuhn. The PI is a tenured professor in the Department of Psychiatry and Behavioral Neurosciences at the Wayne State University School of Medicine, with joint appointments in the Center for Molecular Medicine and Genetics and the Institute of Chemical Toxicology. He has been active in drug abuse research related activities for more than 20 years and has made important contributions to the field in areas relating to: 1) biochemical and molecular characterization of how reactive oxygen and reactive nitrogen species modify the function of protein targets known to be damaged by the neurotoxic amphetamines (eg, monoamine transporters and monooxygenase enzymes); 2) behavioral characterization of hallucinogenic drugs of abuse using drug discrimination techniques; and 3) regulation of the neurochemical function of monoamine neurons. Dr. Kuhn currently devotes 40-50 percent of his time to research and mentoring activities while 50-60 percent of his effort is dedicated to teaching, departmental, and college responsibilities. This Senior Scientist Award will allow him to increase his research effort to approximately 80 percent. The increase in research time will allow Dr. Kuhn the opportunity to develop expertise in and apply new technologies to his research program including the creation of genetic switch (conditional) knock-out mice through homologous recombination, the use of mass spectrometry in characterizing how drugs of abuse modify key proteins in brain, and the application of functional genomics (i.e., microarray analysis) and proteomics to the evaluation of neuronal gene and protein expression patterns related to specific drugs of abuse. In addition, as the PI of a NIDA-funded T32, and as the mentor of graduate students and postdoctoral fellows with NIDA funded F31/32s in his lab, Dr. Kuhn will remain extensively engaged in scientific mentoring activities.
描述:(申请人提供) 这是唐纳德·M·库恩博士的高级科学家奖申请书。圆周率是 精神病学和行为学系终身教授 韦恩州立大学医学院神经科学,联合 分子医学和遗传学中心的任命以及 化学毒理研究所。他一直活跃在药物滥用研究中 从事相关活动20多年,做出了重要贡献 涉及以下领域:1)生物化学和分子 活性氧和活性氮物种如何修饰的表征 已知的被神经毒素损伤的蛋白质靶标的功能 苯丙胺(如单胺转运体和单加氧酶);2) 吸毒致幻药物滥用的行为特征 辨别技术;3)神经化学功能的调节。 单胺类神经元。库恩博士目前将40%-50%的时间用于 研究和指导活动,而他50%-60%的精力是 致力于教学、院系和学院的职责。这位前辈 科学家奖将使他的研究努力增加到大约 80%。研究时间的增加将使库恩博士有机会 在他的研究计划中发展专业知识并应用新技术 包括通过创造遗传开关(条件)基因敲除小鼠 同源重组,使用质谱学来表征如何 滥用药物改变大脑中的关键蛋白质,以及功能性药物的应用 基因组学(即微阵列分析)和蛋白质组学对 与特定药物相关的神经元基因和蛋白表达谱 虐待。此外,作为NIDA资助的T32的PI,以及 研究生和博士后研究员在他的实验室里用NIDA资助的F31/32, 库恩博士将继续广泛参与科学指导活动。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Donald M Kuhn其他文献

Donald M Kuhn的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Donald M Kuhn', 18)}}的其他基金

Humanized Mouse Model of Gulf War Veterans' Illness
海湾战争退伍军人疾病的人源化小鼠模型
  • 批准号:
    10586598
  • 财政年份:
    2023
  • 资助金额:
    $ 12.02万
  • 项目类别:
Gulf War Veterans' Illness: Symptom Chronicity via Interactions of Diet andLifestyle Risk Factors with the Gut Microbiome
海湾战争退伍军人的疾病:饮食和生活方式风险因素与肠道微生物组相互作用导致的慢性症状
  • 批准号:
    10293547
  • 财政年份:
    2020
  • 资助金额:
    $ 12.02万
  • 项目类别:
Gulf War Veterans' Illness: Symptom Chronicity via Interactions of Diet andLifestyle Risk Factors with the Gut Microbiome
海湾战争退伍军人的疾病:饮食和生活方式风险因素与肠道微生物组相互作用导致的慢性症状
  • 批准号:
    10012020
  • 财政年份:
    2020
  • 资助金额:
    $ 12.02万
  • 项目类别:
Delayed and Progressive Emergence of CTE- and Psychiatric-like Pathologies after Repetitive Mild TBI
重复轻度 TBI 后 CTE 和精神病样病理的延迟和进行性出现
  • 批准号:
    10044414
  • 财政年份:
    2020
  • 资助金额:
    $ 12.02万
  • 项目类别:
Delayed and Progressive Emergence of CTE- and Psychiatric-like Pathologies after Repetitive Mild TBI
重复轻度 TBI 后 CTE 和精神病样病理的延迟和进行性出现
  • 批准号:
    10436767
  • 财政年份:
    2020
  • 资助金额:
    $ 12.02万
  • 项目类别:
Gulf War Veterans' Illness: Symptom Chronicity via Interactions of Diet andLifestyle Risk Factors with the Gut Microbiome
海湾战争退伍军人的疾病:饮食和生活方式风险因素与肠道微生物组相互作用导致的慢性症状
  • 批准号:
    10514574
  • 财政年份:
    2020
  • 资助金额:
    $ 12.02万
  • 项目类别:
Delayed and Progressive Emergence of CTE- and Psychiatric-like Pathologies after Repetitive Mild TBI
重复轻度 TBI 后 CTE 和精神病样病理的延迟和进行性出现
  • 批准号:
    9779271
  • 财政年份:
    2020
  • 资助金额:
    $ 12.02万
  • 项目类别:
Delayed and Progressive Emergence of CTE- and Psychiatric-like Pathologies after Repetitive Mild TBI
重复轻度 TBI 后 CTE 和精神病样病理的延迟和进行性出现
  • 批准号:
    10554316
  • 财政年份:
    2020
  • 资助金额:
    $ 12.02万
  • 项目类别:
RR&D Research Career Scientist Award Application
RR
  • 批准号:
    10359710
  • 财政年份:
    2017
  • 资助金额:
    $ 12.02万
  • 项目类别:
RR&D Research Career Scientist Award Application
RR
  • 批准号:
    10574482
  • 财政年份:
    2017
  • 资助金额:
    $ 12.02万
  • 项目类别:

相似海外基金

Effects of HIV-1 Tat protein and methamphetamine on VMAT2-mediated dopamine transmission in the context of neuroHIV and drug abuse
HIV-1 Tat 蛋白和甲基苯丙胺对神经 HIV 和药物滥用背景下 VMAT2 介导的多巴胺传递的影响
  • 批准号:
    10698618
  • 财政年份:
    2023
  • 资助金额:
    $ 12.02万
  • 项目类别:
Genetics of novelty seeking and propensity for drug abuse in outbred rats
近交系大鼠寻求新奇事物的遗传学和药物滥用倾向
  • 批准号:
    10669951
  • 财政年份:
    2023
  • 资助金额:
    $ 12.02万
  • 项目类别:
The ANTIDOTE Institute- Advancing New Toxicology Investigators in Drug abuse and Original Translational research Efforts
ANTIDOTE Institute - 推动新毒理学研究人员在药物滥用和原创转化研究工作中的发展
  • 批准号:
    10681927
  • 财政年份:
    2023
  • 资助金额:
    $ 12.02万
  • 项目类别:
The neuropharmacology of brain activation during stages of drug abuse
药物滥用阶段大脑激活的神经药理学
  • 批准号:
    10681576
  • 财政年份:
    2023
  • 资助金额:
    $ 12.02万
  • 项目类别:
SCC-PG: Securing Underserved Communities from Drug Abuse with Drone-Based Smart Medication Delivery
SCC-PG:通过基于无人机的智能药物输送,确保服务不足的社区免受药物滥用
  • 批准号:
    2231710
  • 财政年份:
    2023
  • 资助金额:
    $ 12.02万
  • 项目类别:
    Standard Grant
Analysis of modulation of the metabotropic glutamate receptor type 5 in a novel heritable model of drug abuse vulnerability
药物滥用易感性新型遗传模型中 5 型代谢型谷氨酸受体的调节分析
  • 批准号:
    10754809
  • 财政年份:
    2023
  • 资助金额:
    $ 12.02万
  • 项目类别:
Using Integrative Data Analysis to Examine the Impact of Psychosocial Treatments for Black Cocaine Users Enrolled in the NIDA Drug Abuse Treatment Clinical Trials Network (CTN)
使用综合数据分析来检查心理社会治疗对参加 NIDA 药物滥用治疗临床试验网络 (CTN) 的黑色可卡因使用者的影响
  • 批准号:
    10683020
  • 财政年份:
    2022
  • 资助金额:
    $ 12.02万
  • 项目类别:
Interdisciplinary Graduate Training through Research in Artificial Intelligence and Secure Networked Sensing to Mitigate the Crisis of Alcohol and Drug Abuse
通过人工智能和安全网络传感研究进行跨学科研究生培训,以缓解酒精和药物滥用危机
  • 批准号:
    2152057
  • 财政年份:
    2022
  • 资助金额:
    $ 12.02万
  • 项目类别:
    Standard Grant
Great Lakes Node of the Drug Abuse Clinical Trials Network
药物滥用临床试验网络五大湖节点
  • 批准号:
    10662573
  • 财政年份:
    2022
  • 资助金额:
    $ 12.02万
  • 项目类别:
Great Lakes Node of the Drug Abuse Clinical Trials Network
药物滥用临床试验网络五大湖节点
  • 批准号:
    10583828
  • 财政年份:
    2022
  • 资助金额:
    $ 12.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了